Based on recent data, Elicio Therapeutics, Inc. (ELTX) shows an Average True Range (ATR) of 0.75 and an Enterprise Value of N/A. Its average trading volume over the past 3 months is 135.18K, indicating liquidity. These fundamental metrics provide insight into ELTX's underlying financial health and market activity.
| ATR | 0.75 |
| Enterprise Value | - |
| Avg Vol (3 Months) | 135.18K |
| Avg Vol (10 Days) | 175.67K |
Elicio Therapeutics, Inc. (ELTX) technical indicators as of June 11, 2026: the SMA 20 is 33.3%, SMA 50 at 40.47%, and SMA 200 at 31.09%. The RSI 14 value is 77.6, suggesting its current momentum. These technical analysis signals help assess ELTX's price trends and potential future movements.
| SMA 20 | 33.3% |
| SMA 50 | 40.47% |
| SMA 200 | 31.09% |
| RSI 14 | 77.6 |
Elicio Therapeutics, Inc. (ELTX) stock performance overview as of June 11, 2026: The 52-week high is $16 (currently -6.97% below), and the 52-week low is $7.37 (currently 155.22% above). Over the past year, ELTX's performance is 23.45%, compared to the S&P 500's 9.37% change.
| 52-Week High | 16 |
| 52-Week High Chg | -6.97% |
| 52-Week Low | 7.37 |
| 52-Week Low Chg | +155.22% |
| S&P 500 52-Week Chg | 9.37% |
According to market data, Elicio Therapeutics, Inc. (ELTX) stock's recent performance metrics show that over the last month, ELTX is 1.02%, with a Year-to-Date (YTD) performance of -0.13%. Over the past year, the stock has seen a 23.45% change. These figures summarize ELTX's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 16 | 16 | 16 | 16 | 16 | 16 |
| Low | 12.76 | 9.12 | 9.12 | 7.37 | 7.37 | 7.37 |
| Performance | +2.71% | +1.02% | -14.97% | -13.96% | +23.45% | -0.13% |
According to current financial data, ELTX stock's P/E (TTM) ratio is -6.47, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for ELTX, including P/S (N/A), P/B (-180.91), and P/FCF (-7.08), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | ELTX | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -6.47 | -1.22 | -5.12 | 32.59 |
| P/S (TTM) | N/A | 3.69 | 464.32 | 5.98 |
| P/B (TTM) | -180.91 | 3.7 | 10.92 | 5.27 |
| P/FCF (TTM) | -7.08 | 28.68 | -912.14 | 29.85 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep